Otsuka Holdings Rises as BofAML Expects Profit to Beat Forecast
Alert: HALISTER1
Source: BFW (Bloomberg First Word)
Tickers
4578 JP (Otsuka Holdings Co Ltd)
People
Ritsuo Watanabe (Merrill Lynch Japan Securities Co Ltd)
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283
(Bloomberg) -- Otsuka profit will be boosted by high-margin drugs Rexulti and Maintena, unused R&D funds, analyst Ritsuo Watanabe writes in note dated March 9.
- Upgrades rating to buy from neutral, PT to 6,200 yen from 5,900 yen
- Sees 133.9b yen operating profit for year ending Dec. 2017 vs co. forecast of 120b yen
- Shares rise as much as 5.3%, most since Jan. 10; trading volume ~60% of 3-month avg
- 5 buys, 6 holds, 1 sell; avg PT 5,452.50 yen: Bloomberg data
Alert: HALISTER1
Source: BFW (Bloomberg First Word)
Tickers
4578 JP (Otsuka Holdings Co Ltd)
People
Ritsuo Watanabe (Merrill Lynch Japan Securities Co Ltd)
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283